These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 7206835)

  • 21. Clorgyline and deprenyl insensitive monoamine oxidase in rat brain soluble fraction.
    Shekhar C; Mayanil K; Baquer NZ
    Biochem Pharmacol; 1982 Dec; 31(23):3925-7. PubMed ID: 6818972
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The potentiating effect of clorgyline and pyrogallol on the blood pressure responses to norepinephrine.
    Lai FM; Spector S
    Arch Int Pharmacodyn Ther; 1978 Aug; 234(2):279-86. PubMed ID: 708154
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of central and peripheral carbohydrate reserves after selective inhibition of enzyme monoamine oxidase: comparison between fed and starved rats.
    Parvez H; Ismahan G; Parvez S; Youdim MB
    J Pharmacol; 1981; 12(2):123-33. PubMed ID: 6790875
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Monoamine oxidase activity and gamma-aminobutyric acid levels in hyperoxia. The effect of clorgyline].
    Goroshinskaia IA; Krichevskaia AA; Shugaleĭ VS; Sherstnev KB; Balamirzoeva RM
    Vopr Med Khim; 1986; 32(2):76-9. PubMed ID: 3705520
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhancement of rat brain cytosolic monoamine oxidase activity by clorgyline. Comparison with (-)-deprenyl and MDL 72145.
    Azam M; Jain S; Baquer NZ
    Biochem Pharmacol; 1990 Nov; 40(10):2215-8. PubMed ID: 2123104
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potentiation of 3,4-methylenedioxymethamphetamine-induced 5-HT release in the rat substantia nigra by clorgyline, a monoamine oxidase A inhibitor.
    Hewton R; Salem A; Irvine RJ
    Clin Exp Pharmacol Physiol; 2007 Oct; 34(10):1051-7. PubMed ID: 17714093
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Are there MAO inhibitors specific for dopamine metabolism?
    Youdim MB; Holzbauer M
    Adv Biochem Psychopharmacol; 1977; 16():349-58. PubMed ID: 329649
    [No Abstract]   [Full Text] [Related]  

  • 28. The inhibition by clorgyline of 5-hydroxytryptamine deamination by the rat liver.
    Fowler CJ; Callingham BA
    J Pharm Pharmacol; 1978 May; 30(5):304-9. PubMed ID: 26745
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Interaction between clorgyline and reserpine on the arterial blood pressure on the spinal cat (author's transl)].
    Galiana J; Alamo C; Cuenca E
    Arch Farmacol Toxicol; 1977 Aug; 3(2):109-16. PubMed ID: 921331
    [No Abstract]   [Full Text] [Related]  

  • 30. Observations on the inhibition of rat liver monoamine oxidase by clorgyline.
    Lyles GA; Greenawalt JW
    Biochem Pharmacol; 1977 Dec; 26(23):2269-74. PubMed ID: 588309
    [No Abstract]   [Full Text] [Related]  

  • 31. Inhibition of mitochondrial monoamine oxidase of the rat uterus and liver by clorglyine, pargyline and harmine.
    Grosso DS; Gawienowski AM
    Biochem Pharmacol; 1976 Apr; 25(8):957-61. PubMed ID: 178322
    [No Abstract]   [Full Text] [Related]  

  • 32. [Determination of monoamine oxidase activity in a coupled reaction with alcohol dehydrogenase].
    Verevkina IV; Iakusheva MI
    Vopr Med Khim; 1977; (3):412-9. PubMed ID: 888410
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Brain monoamine oxidase in suckling rabbits treated with organophosphorus compound. I. Acute intoxication.
    Maślińska D
    Acta Physiol Pol; 1984; 35(2):137-40. PubMed ID: 6443171
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inactivation of cytochrome P4502B1 by the monoamine oxidase inhibitors R-(-)-deprenyl and clorgyline.
    Sharma U; Roberts ES; Hollenberg PF
    Drug Metab Dispos; 1996 Jun; 24(6):669-75. PubMed ID: 8781784
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of monoamine oxidase inhibition on the regional cerebral blood flow response to circulating noradrenaline.
    Lasbennes F; Lacombe P; Seylaz J
    Brain Res; 1988 Jun; 454(1-2):205-11. PubMed ID: 3409003
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Crystallization and preliminary crystallographic analysis of rat monoamine oxidase A complexed with clorgyline.
    Ma J; Kubota F; Yoshimura M; Yamashita E; Nakagawa A; Ito A; Tsukihara T
    Acta Crystallogr D Biol Crystallogr; 2004 Feb; 60(Pt 2):317-9. PubMed ID: 14747710
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Species-dependent differences in monoamine oxidase A and B-catalyzed oxidation of various C4 substituted 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridinyl derivatives.
    Inoue H; Castagnoli K; Van Der Schyf C; Mabic S; Igarashi K; Castagnoli N
    J Pharmacol Exp Ther; 1999 Nov; 291(2):856-64. PubMed ID: 10525109
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Monoamine oxidase activity and effect of clorgyline on the polyamine level during hyperoxia in rats].
    Goroshinskaia IA; Tsvetnenko EZ; Khodakova AA; Frenkel' ML; Gorkin VZ
    Ukr Biokhim Zh (1978); 1986; 58(3):74-7. PubMed ID: 3727040
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and monoamine oxidase inhibitory activities of 1-thiocarbamoyl-3,5-diphenyl-4,5-dihydro-1H-pyrazole derivatives.
    Palaska E; Aydin F; Uçar G; Erol D
    Arch Pharm (Weinheim); 2008 Apr; 341(4):209-15. PubMed ID: 18266289
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structure of rat monoamine oxidase A and its specific recognitions for substrates and inhibitors.
    Ma J; Yoshimura M; Yamashita E; Nakagawa A; Ito A; Tsukihara T
    J Mol Biol; 2004 Apr; 338(1):103-14. PubMed ID: 15050826
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.